Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells

Jason S Kirk1, Jie Wang2, Mark Long2

  • 1Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

Cell Stem Cell
|June 15, 2024
PubMed

Insights

This study created a mouse prostate single-cell atlas to understand castration resistance in prostate cancer (PCa). It identified distinct cell populations and key pathways driving resistance, offering insights for advanced PCa treatments.

Area of Science:

  • Oncology
  • Genomics
  • Cell Biology

Background:

  • Prostate cancer (PCa) response to castration and androgen receptor signaling inhibitors (ARSI) is crucial for patient survival.
  • Understanding the cellular mechanisms of castration resistance is essential for developing effective treatments.

Purpose of the Study:

  • To create a comprehensive mouse single-cell reference atlas of the prostate.
  • To interpret mouse prostate biology and castration response using multi-omics data.
  • To identify key molecular pathways driving castration resistance in PCa.

Main Methods:

  • Utilized a multi-omics approach on 229,794 single cells.
  • Developed a mouse single-cell reference atlas.
  • Integrated lineage tracing and molecular pathway analysis.

Main Results:

  • The reference atlas refined single-cell annotations and provided chromatin context.
  • Castration-resistant luminal cells were identified as distinct from urethra-proximal stem/progenitor cells.
  • AP1, WNT/β-catenin, FOXQ1, NF-κB, and JAK/STAT pathways were implicated as major drivers of castration-resistant luminal populations.

Conclusions:

  • The developed mouse prostate atlas aids in interpreting castration response.
  • Identified distinct cell populations and pathways driving castration resistance in PCa.
  • Findings are relevant to human PCa and can inform combination therapies with ARSI.

Related Concept Videos